The drugmaker and group purchasing organization will focus on two major projects: a preventative care model to address low vaccination rates and a chronic disease model for patients with type 2 diabetes and osteoporosis.
“Our expanded collaboration allows us to more effectively support health systems and clinicians that are evolving from volume to value-based models, but lack adequate prevention and wellness solutions,” Mimi Huizinga, MD, Premier’s chief health information office, said in a news release. “We’ve been working with Merck to design data-driven interventions for some of the top population health challenges facing our country, and we’re eager to start testing them in the real world.”
More articles on supply chain:
Lucid Pharma recalls 69k bottles of antidepressant over quality issues
Why this drugmaker invests in clean coal
FDA approves Shire’s ADHD drug: 3 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.